Failure of metoclopramide-induced acute hyperprolactinemia to affect time of ovulation or spontaneous luteolysis in the cycling mare

S. E. Becker, Alan Leslie Johnson

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

Two studies were conducted to evaluate the effects of acute hyperprolactinemia on : 1) the timing of ovulation and 2) the termination of the luteal phase in Standardbred mares. Persistently elevated prolactin levels were established in regularly cycling mares by administering 25 mg metoclopramide (MCP; a dopamine antagonist), i.v., every 2 hours for 4 days, beginning either day 17 (follicular phase) or day 11 (luteal phase) of the estrous cycle. Control mares received saline only. In the first experiment (during the follicular phase), the number of days to ovulation from the start of infusion did not significantly differ between the MCP- and vehicle-treated groups (5.4±0.5 versus 6.3±1.3 days, respectively; P<.10). Profiles of serum concentrations of follicle stimulating hormone (FSH) and of luteinizing hormone (LH) aligned relative to day of ovulation were similar between treatment groups. In the second study (during the luteal phase), neither time to termination of the luteal phase (6.0±0.3 versus 5.3±0.3 days from start of treatment) nor time to ovulation (12.8±1.5 versus 9.8±0.5 days) was different in MCP- compared to vehicle-treated mares, respectively (P>0.05). Profiles of serum concentrations of progesterone, FSH and LH aligned relative to days from previous ovulation were not altered by MCP treatment. We conclude that a short-term elevation in serum prolactin, such as that which occurs during the immediate post-partum period, does not alter luteal function or the timing of ovulation in the cycling horse mare.

Original languageEnglish (US)
Pages (from-to)275-279
Number of pages5
JournalJournal of Equine Veterinary Science
Volume10
Issue number4
DOIs
StatePublished - Jan 1 1990

Fingerprint

metoclopramide
Luteolysis
Hyperprolactinemia
Metoclopramide
luteolysis
Ovulation
mares
ovulation
corpus luteum
Follicular Phase
Luteal Phase
prolactin
Prolactin
Estrous Cycle
Dopamine Antagonists
Standardbred
Corpus Luteum
postpartum period
dopamine
Serum

All Science Journal Classification (ASJC) codes

  • Equine

Cite this

@article{0f4e186c473849edb2a6020cefde4ec3,
title = "Failure of metoclopramide-induced acute hyperprolactinemia to affect time of ovulation or spontaneous luteolysis in the cycling mare",
abstract = "Two studies were conducted to evaluate the effects of acute hyperprolactinemia on : 1) the timing of ovulation and 2) the termination of the luteal phase in Standardbred mares. Persistently elevated prolactin levels were established in regularly cycling mares by administering 25 mg metoclopramide (MCP; a dopamine antagonist), i.v., every 2 hours for 4 days, beginning either day 17 (follicular phase) or day 11 (luteal phase) of the estrous cycle. Control mares received saline only. In the first experiment (during the follicular phase), the number of days to ovulation from the start of infusion did not significantly differ between the MCP- and vehicle-treated groups (5.4±0.5 versus 6.3±1.3 days, respectively; P<.10). Profiles of serum concentrations of follicle stimulating hormone (FSH) and of luteinizing hormone (LH) aligned relative to day of ovulation were similar between treatment groups. In the second study (during the luteal phase), neither time to termination of the luteal phase (6.0±0.3 versus 5.3±0.3 days from start of treatment) nor time to ovulation (12.8±1.5 versus 9.8±0.5 days) was different in MCP- compared to vehicle-treated mares, respectively (P>0.05). Profiles of serum concentrations of progesterone, FSH and LH aligned relative to days from previous ovulation were not altered by MCP treatment. We conclude that a short-term elevation in serum prolactin, such as that which occurs during the immediate post-partum period, does not alter luteal function or the timing of ovulation in the cycling horse mare.",
author = "Becker, {S. E.} and Johnson, {Alan Leslie}",
year = "1990",
month = "1",
day = "1",
doi = "10.1016/S0737-0806(06)80010-9",
language = "English (US)",
volume = "10",
pages = "275--279",
journal = "Journal of Equine Veterinary Science",
issn = "0737-0806",
publisher = "W.B. Saunders Ltd",
number = "4",

}

Failure of metoclopramide-induced acute hyperprolactinemia to affect time of ovulation or spontaneous luteolysis in the cycling mare. / Becker, S. E.; Johnson, Alan Leslie.

In: Journal of Equine Veterinary Science, Vol. 10, No. 4, 01.01.1990, p. 275-279.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Failure of metoclopramide-induced acute hyperprolactinemia to affect time of ovulation or spontaneous luteolysis in the cycling mare

AU - Becker, S. E.

AU - Johnson, Alan Leslie

PY - 1990/1/1

Y1 - 1990/1/1

N2 - Two studies were conducted to evaluate the effects of acute hyperprolactinemia on : 1) the timing of ovulation and 2) the termination of the luteal phase in Standardbred mares. Persistently elevated prolactin levels were established in regularly cycling mares by administering 25 mg metoclopramide (MCP; a dopamine antagonist), i.v., every 2 hours for 4 days, beginning either day 17 (follicular phase) or day 11 (luteal phase) of the estrous cycle. Control mares received saline only. In the first experiment (during the follicular phase), the number of days to ovulation from the start of infusion did not significantly differ between the MCP- and vehicle-treated groups (5.4±0.5 versus 6.3±1.3 days, respectively; P<.10). Profiles of serum concentrations of follicle stimulating hormone (FSH) and of luteinizing hormone (LH) aligned relative to day of ovulation were similar between treatment groups. In the second study (during the luteal phase), neither time to termination of the luteal phase (6.0±0.3 versus 5.3±0.3 days from start of treatment) nor time to ovulation (12.8±1.5 versus 9.8±0.5 days) was different in MCP- compared to vehicle-treated mares, respectively (P>0.05). Profiles of serum concentrations of progesterone, FSH and LH aligned relative to days from previous ovulation were not altered by MCP treatment. We conclude that a short-term elevation in serum prolactin, such as that which occurs during the immediate post-partum period, does not alter luteal function or the timing of ovulation in the cycling horse mare.

AB - Two studies were conducted to evaluate the effects of acute hyperprolactinemia on : 1) the timing of ovulation and 2) the termination of the luteal phase in Standardbred mares. Persistently elevated prolactin levels were established in regularly cycling mares by administering 25 mg metoclopramide (MCP; a dopamine antagonist), i.v., every 2 hours for 4 days, beginning either day 17 (follicular phase) or day 11 (luteal phase) of the estrous cycle. Control mares received saline only. In the first experiment (during the follicular phase), the number of days to ovulation from the start of infusion did not significantly differ between the MCP- and vehicle-treated groups (5.4±0.5 versus 6.3±1.3 days, respectively; P<.10). Profiles of serum concentrations of follicle stimulating hormone (FSH) and of luteinizing hormone (LH) aligned relative to day of ovulation were similar between treatment groups. In the second study (during the luteal phase), neither time to termination of the luteal phase (6.0±0.3 versus 5.3±0.3 days from start of treatment) nor time to ovulation (12.8±1.5 versus 9.8±0.5 days) was different in MCP- compared to vehicle-treated mares, respectively (P>0.05). Profiles of serum concentrations of progesterone, FSH and LH aligned relative to days from previous ovulation were not altered by MCP treatment. We conclude that a short-term elevation in serum prolactin, such as that which occurs during the immediate post-partum period, does not alter luteal function or the timing of ovulation in the cycling horse mare.

UR - http://www.scopus.com/inward/record.url?scp=85008347796&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85008347796&partnerID=8YFLogxK

U2 - 10.1016/S0737-0806(06)80010-9

DO - 10.1016/S0737-0806(06)80010-9

M3 - Article

AN - SCOPUS:85008347796

VL - 10

SP - 275

EP - 279

JO - Journal of Equine Veterinary Science

JF - Journal of Equine Veterinary Science

SN - 0737-0806

IS - 4

ER -